REQUEST A DEMO
Total
USD $0.00
Search more companies

Pfizer Kft. (Hungary)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Pfizer Gyogyszerkereskedelmi Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Pfizer Gyogyszerkereskedelmi Kft is a pharmaceutical and biotechnology company focused on developing medicines and vaccines. The company provides therapies in areas such as oncology, inflammatory and autoimmune diseases, cardiovascular disease, pain relief, nervous system illnesses, vaccines, and rare diseases. Pfizer conducts clinical research, supports health institutions, and collaborates with various stakeholders to develop new therapeutic solutions. The company is also involved in disease prevention and initiatives to combat drug counterfeiting.

Headquarters
Alkotas u. 53.
Budapest; Budapest; Postal Code: 1123

Contact Details: Purchase the Pfizer Kft. report to view the information.

Website: http://www.pfizer.hu

Basic Information
Total Employees:
Purchase the Pfizer Kft. report to view the information.
Outstanding Shares:
Purchase the Pfizer Kft. report to view the information.
Registered Capital:
Purchase the Pfizer Kft. report to view the information.
Financial Auditors:
Purchase the Pfizer Kft. report to view the information.
Incorporation Date:
May 21, 1991
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Pfizer Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
-27.47%
Total operating revenue
-28.23%
Operating profit (EBIT)
-23.13%
EBITDA
-22.81%
Net Profit (Loss) for the Period
-8.96%
Total assets
-0.31%
Total equity
-11.16%
Operating Profit Margin (ROS)
0.31%
Net Profit Margin
1.18%
Return on Equity (ROE)
0.66%
Debt to Equity Ratio
0%
Quick Ratio
-0.37%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?